Kiwoom Investment — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations.
Biotech
Seulki Lee(Executive Officer, Director)inSunghoon Hong(Executive Officer, Director)Sungmook Lim(Executive Officer, Director)
BoardDaehyun Shin(Director)Seungwon Lim(Director)Seol-Heui Han(Director)
Co-investorsDAYLI PartnersLB InvestmentOctave Ventures Llc
Datumo Eval is an LLM evaluation platform that generates industry-specific question datasets from source documents and assesses LLM models and LLM-powered services using default or custom metrics via an agentic flow of multiple LLM agents.
AI & Machine LearningCybersecurityData & InfrastructureDeveloper Tools
Michael Hwang(Founder)inMichael (Minyoung) Hwang(Founder)in
Co-investorsACVC PartnersKB InvestmentSalesforce VenturesSBI InvestmentShinhan Venture Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.